91.5FM
91.5HD2
8.85 c91.5 FM
91.5 HD2
Russia's Sputnik V gets Emergency Use Authorisation nod in India
BY , Apr 12, 2021 4:46 PM - REPORT AN ERROR
An image of Russia's Sputnik V vaccine vial/ ANI
Russia's Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India.
According to sources, the SEC approved Dr Reddy's application for EUA to Sputnik V.
The decision comes after the Drugs Controller General of India (DCGI)'s SEC met today to take up Sputnik V application for EUA in India.
Dr Reddy's Laboratories, last week sought the government's approval for the vaccine to be used in India. The Russian Direct Investment Fund (RDIF) partnered with Dr Reddy's in September 2020 to conduct clinical trials of Sputnik V in India.
DCGI had then sought additional data from drugmaker Dr Reddy's Laboratories on its Sputnik V Covid-19 vaccine trial.
India is currently manufacturing two Covid-19 vaccines, --- Serum Institute of India's locally-made Oxford Covid-19 vaccine 'Covishield' and Bharat Biotech's indigenously manufactured Covaxin.
Share on
Related News
Sign up for the newsletter
We'll deliver best of entertainment right into your inboxWe love to hear from our listeners, so feel free to send us message
Message us on whatsapp
